Carmichael Hill & Associates’s Boston Scientific BSX Stock Holding History

Carmichael Hill & Associates’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-105	Closed	-$4K	–	794
2022 Q3	$4K	Hold	105	–	–	﹤0.01%	679
2022 Q2	$4K	Hold	105	–	–	﹤0.01%	672
2022 Q1	$5K	Hold	105	–	–	﹤0.01%	680
2021 Q4	$4K	Hold	105	–	–	﹤0.01%	718
2021 Q3	$5K	Hold	105	–	–	﹤0.01%	685
2021 Q2	$4K	Hold	105	–	–	﹤0.01%	686
2021 Q1	$4K	Hold	105	–	–	﹤0.01%	669
2020 Q4	$4K	Hold	105	–	–	﹤0.01%	645
2020 Q3	$4K	Hold	105	–	–	﹤0.01%	598
2020 Q2	$4K	Hold	105	–	–	﹤0.01%	561
2020 Q1	$3K	Hold	105	–	–	﹤0.01%	565
2019 Q4	$5K	Buy	+105	New	+$4.39K	﹤0.01%	548

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Carmichael Hill & Associates's BSX Position: Q4 2022 in Review

Carmichael Hill & Associates sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 105 shares — an estimated $4K sold.

Carmichael Hill & Associates first reported a position in BSX in Q4 2019 and held it in 12 quarters. The position peaked at $5K in Q1 2022. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

Carmichael Hill & Associates reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
Carmichael Hill & Associates sold 105 Boston Scientific shares in Q4 2022, an estimated $4K.
Carmichael Hill & Associates first reported a position in Boston Scientific in Q4 2019 and held it in 12 quarters.
Carmichael Hill & Associates's Boston Scientific position peaked at $5K in Q1 2022.
928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Carmichael Hill & Associates's 13F filing for Q4 2022, filed 14 Feb 2023.